Sanjeev Narula - Feb 3, 2025 Form 4 Insider Report for Intra-Cellular Therapies, Inc. (ITCI)

Role
Executive Vice President & CFO
Signature
/s/ John P. Condon, Attorney-in-fact
Stock symbol
ITCI
Transactions as of
Feb 3, 2025
Transactions value $
$0
Form type
4
Date filed
2/4/2025, 05:01 PM
Previous filing
Aug 14, 2024
Next filing
Apr 2, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ITCI Restricted Stock Units Award $0 +22.7K $0.00 22.7K Feb 3, 2025 Common Stock 22.7K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock.
F2 On February 3, 2025, the reporting person was granted 22,727 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.